Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer
Status:
Terminated
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The overall purpose of this research is to evaluate the safety and side effects of zoledronic
acid (also known as Zometa) in patients before they have surgery to remove the cancer.